Abstract
Due to the lower risks of adverse effects, nonviral gene therapy is a suitable alternative to transfect cancer cells with a suicide gene to let them kill themselves by expressing toxic ribosome-inactivating proteins. Plasmids are stable and easy-to-produce vectors, but they have some disadvantages due to the bacterial backbone. Applying the minicircle technology, this problem can be solved with manageable effort in a well-equipped laboratory. With the described methodology, minicircle-DNA can be produced at low costs. The cell killing properties are monitored following transfection using the CytoSMART® Omni system—a camera based live cell imaging device.
Key words
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Navarro SA, Carrillo E, Griñán-Lisón C et al (2016) Cancer suicide gene therapy: a patent review. Expert Opin Ther Pat 26(9):1095–1104. https://doi.org/10.1080/13543776.2016.1211640
Weise C, Schrot A, Wuerger LTD et al (2020) An unusual type I ribosome-inactivating protein from Agrostemma githago L. Sci Rep 10(1):15377. https://doi.org/10.1038/s41598-020-72282-2
Endo Y, Mitsui K, Motizuki M et al (1987) The mechanism of action of ricin and related toxic lectins on eukaryotic ribosomes. The site and the characteristics of the modification in 28S ribosomal RNA caused by the toxins. J Biol Chem 262(12):5908–5912. https://doi.org/10.1016/S0021-9258(18)45660-8
Barbieri L, Battelli MG, Stirpe F (1993) Ribosome-inactivating proteins from plants. BBA 1154(3):237–282. https://doi.org/10.1016/0304-4157(93)90002-6
Schrot J, Weng A, Melzig MF (2015) Ribosome-inactivating and related proteins. Toxins 7(5):1556–1615. https://doi.org/10.3390/toxins7051556
Sama S, Woith E, Walther W et al (2018) Targeted suicide gene transfections reveal promising results in nu/nu mice with aggressive neuroblastoma. J Control Release 275:208–216. https://doi.org/10.1016/j.jconrel.2018.02.031
Zarovni N, Vago R, Fabbrini MS (2009) Saporin suicide gene therapy. Methods Mol Biol 542:261–283. https://doi.org/10.1007/978-1-59745-561-9_14
Zarovni N, Vago R, Soldà T et al (2007) Saporin as a novel suicide gene in anticancer gene therapy. Cancer Gene Ther 14(2):165–173. https://doi.org/10.1038/sj.cgt.7700998
Baum C, Kustikova O, Modlich U et al (2006) Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors. Hum Gene Ther 17(3):253–263. https://doi.org/10.1089/hum.2006.17.253
Jooss K, Chirmule N (2003) Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy. Gene Ther 10(11):955–963. https://doi.org/10.1038/sj.gt.3302037
Kremer EJ (2020) Pros and cons of adenovirus-based SARS-CoV-2 vaccines. Mol Ther 28(11):2303–2304. https://doi.org/10.1016/j.ymthe.2020.10.002
Klinman DM (2004) Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat Rev Immunol 4(4):249–259. https://doi.org/10.1038/nri1329
European Medicines Agency (2018) Guideline on the quality, non-clinical and clinical aspects of gene therapy medicinal products. European Medicines Agency. EMA/CAT/80183/2014
Chen ZY, He CY, Ehrhardt A et al (2003) Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. Mol Ther 8(3):495–500. https://doi.org/10.1016/s1525-0016(03)00168-0
Jia F, Wilson KD, Sun N et al (2010) A nonviral minicircle vector for deriving human iPS cells. Nat Methods 7(3):197–199. https://doi.org/10.1038/nmeth.1426
Kay MA, He CY, Chen ZY (2010) A robust system for production of minicircle DNA vectors. Nat Biotechnol 28(12):1287–1289. https://doi.org/10.1038/nbt.1708
Weng A, Manunta MD, Thakur M et al (2015) Improved intracellular delivery of peptide- and lipid-nanoplexes by natural glycosides. J Control Release 206:75–90. https://doi.org/10.1016/j.jconrel.2015.03.007
Clochard J, Jerz G, Schmieder P et al (2020) A new acetylated triterpene saponin from Agrostemma githago L. modulates gene delivery efficiently and shows a high cellular tolerance. Int J Pharm 589:119822. https://doi.org/10.1016/j.ijpharm.2020.119822
van Loosdregt I, Koonen-Reemst A, Maltha J (2018) Long-term, noninvasive, viability monitoring of paclitaxel treated cells (Application note. 0004)
Mitdank H, Sama S, Tröger M et al (2021) An advanced method for the small-scale production of high-quality minicircle DNA. Int J Pharm 605:120830. https://doi.org/10.1016/j.ijpharm.2021.120830
Gentechnische Methoden: Eine Sammlung von Arbeitsanleitungen für das molekularbiologische Labor. 5. Auflage edn. Spektrum Akademischer Verlag, Heidelberg. https://doi.org/10.1007/978-3-8274-2430-3
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Sonntag, A., Mitdank, H., Weng, A. (2022). Construction of Minicircle Suicide Genes Coding for Ribosome-Inactivating Proteins. In: Walther, W. (eds) Gene Therapy of Cancer. Methods in Molecular Biology, vol 2521. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2441-8_8
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2441-8_8
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2440-1
Online ISBN: 978-1-0716-2441-8
eBook Packages: Springer Protocols